 | • レポートコード：QAF27570 • 出版社/出版日：QYResearch / 2021年4月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の抗毒素市場について種類別（多価抗毒素、一価抗毒素）、用途別（非営利団体、病院＆クリニック）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗毒素市場の概要 ・世界の主要地域別抗毒素市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の抗毒素市場規模2016-2021：種類別（多価抗毒素、一価抗毒素） ・世界の抗毒素市場予測2012-2027：種類別（多価抗毒素、一価抗毒素） ・世界の抗毒素市場規模2016-2021：用途別（非営利団体、病院＆クリニック） ・世界の抗毒素市場予測2012-2027：用途別（非営利団体、病院＆クリニック） ・抗毒素のアメリカ市場規模と予測2016-2021 ・抗毒素のヨーロッパ市場規模と予測2016-2021 ・抗毒素の中国市場規模と予測2016-2021 ・抗毒素の日本市場規模と予測2016-2021 ・抗毒素の東南アジア市場規模と予測2016-2021 ・抗毒素のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm） ・抗毒素の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗毒素の市場動向・機会・課題 ・調査の結論 |
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
Market Analysis and Insights: Global Antivenom Market
The global Antivenom market was valued at US$ 959.2 in 2020 and will reach US$ 1227.8 million by the end of 2027, growing at a CAGR of 4.2% during 2022-2027.
Global Antivenom Scope and Market Size
The global Antivenom market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antivenom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Polyvalent antivenom
Monovalent antivenom
Segment by Application
Non-profit Institutions
Hospitals and Clinic
The Antivenom market is analysed and market size information is provided by regions (countries). Segment by Application, the Antivenom market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
1 Antivenom Market Overview
1.1 Antivenom Product Scope
1.2 Antivenom Segment by Type
1.2.1 Global Antivenom Sales by Type (2016 & 2021 & 2027)
1.2.2 Polyvalent antivenom
1.2.3 Monovalent antivenom
1.3 Antivenom Segment by Application
1.3.1 Global Antivenom Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Antivenom Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antivenom Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antivenom Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antivenom Price Trends (2016-2027)
2 Antivenom Estimates and Forecasts by Region
2.1 Global Antivenom Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antivenom Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antivenom Sales Market Share by Region (2016-2021)
2.2.2 Global Antivenom Revenue Market Share by Region (2016-2021)
2.3 Global Antivenom Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antivenom Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antivenom Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antivenom Estimates and Projections (2016-2027)
2.4.2 Europe Antivenom Estimates and Projections (2016-2027)
2.4.3 China Antivenom Estimates and Projections (2016-2027)
2.4.4 Japan Antivenom Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antivenom Estimates and Projections (2016-2027)
2.4.6 India Antivenom Estimates and Projections (2016-2027)
3 Global Antivenom Competition Landscape by Players
3.1 Global Top Antivenom Players by Sales (2016-2021)
3.2 Global Top Antivenom Players by Revenue (2016-2021)
3.3 Global Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antivenom as of 2020)
3.4 Global Antivenom Average Price by Company (2016-2021)
3.5 Manufacturers Antivenom Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antivenom Market Size by Type
4.1 Global Antivenom Historic Market Review by Type (2016-2021)
4.1.1 Global Antivenom Sales Market Share by Type (2016-2021)
4.1.2 Global Antivenom Revenue Market Share by Type (2016-2021)
4.1.3 Global Antivenom Price by Type (2016-2021)
4.2 Global Antivenom Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antivenom Sales Forecast by Type (2022-2027)
4.2.2 Global Antivenom Revenue Forecast by Type (2022-2027)
4.2.3 Global Antivenom Price Forecast by Type (2022-2027)
5 Global Antivenom Market Size by Application
5.1 Global Antivenom Historic Market Review by Application (2016-2021)
5.1.1 Global Antivenom Sales Market Share by Application (2016-2021)
5.1.2 Global Antivenom Revenue Market Share by Application (2016-2021)
5.1.3 Global Antivenom Price by Application (2016-2021)
5.2 Global Antivenom Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antivenom Sales Forecast by Application (2022-2027)
5.2.2 Global Antivenom Revenue Forecast by Application (2022-2027)
5.2.3 Global Antivenom Price Forecast by Application (2022-2027)
6 North America Antivenom Market Facts & Figures
6.1 North America Antivenom Sales by Company
6.1.1 North America Antivenom Sales by Company (2016-2021)
6.1.2 North America Antivenom Revenue by Company (2016-2021)
6.2 North America Antivenom Sales Breakdown by Type
6.2.1 North America Antivenom Sales Breakdown by Type (2016-2021)
6.2.2 North America Antivenom Sales Breakdown by Type (2022-2027)
6.3 North America Antivenom Sales Breakdown by Application
6.3.1 North America Antivenom Sales Breakdown by Application (2016-2021)
6.3.2 North America Antivenom Sales Breakdown by Application (2022-2027)
7 Europe Antivenom Market Facts & Figures
7.1 Europe Antivenom Sales by Company
7.1.1 Europe Antivenom Sales by Company (2016-2021)
7.1.2 Europe Antivenom Revenue by Company (2016-2021)
7.2 Europe Antivenom Sales Breakdown by Type
7.2.1 Europe Antivenom Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antivenom Sales Breakdown by Type (2022-2027)
7.3 Europe Antivenom Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Antivenom Market Facts & Figures
8.1 China Antivenom Sales by Company
8.1.1 China Antivenom Sales by Company (2016-2021)
8.1.2 China Antivenom Revenue by Company (2016-2021)
8.2 China Antivenom Sales Breakdown by Type
8.2.1 China Antivenom Sales Breakdown by Type (2016-2021)
8.2.2 China Antivenom Sales Breakdown by Type (2022-2027)
8.3 China Antivenom Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Antivenom Market Facts & Figures
9.1 Japan Antivenom Sales by Company
9.1.1 Japan Antivenom Sales by Company (2016-2021)
9.1.2 Japan Antivenom Revenue by Company (2016-2021)
9.2 Japan Antivenom Sales Breakdown by Type
9.2.1 Japan Antivenom Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antivenom Sales Breakdown by Type (2022-2027)
9.3 Japan Antivenom Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Antivenom Market Facts & Figures
10.1 Southeast Asia Antivenom Sales by Company
10.1.1 Southeast Asia Antivenom Sales by Company (2016-2021)
10.1.2 Southeast Asia Antivenom Revenue by Company (2016-2021)
10.2 Southeast Asia Antivenom Sales Breakdown by Type
10.2.1 Southeast Asia Antivenom Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antivenom Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antivenom Sales Breakdown by Application
10.3.1 Southeast Asia K Vials Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Vials Sales Breakdown by Application (2022-2027)
11 India Antivenom Market Facts & Figures
11.1 India Antivenom Sales by Company
11.1.1 India Antivenom Sales by Company (2016-2021)
11.1.2 India Antivenom Revenue by Company (2016-2021)
11.2 India Antivenom Sales Breakdown by Type
11.2.1 India Antivenom Sales Breakdown by Type (2016-2021)
11.2.2 India Antivenom Sales Breakdown by Type (2022-2027)
11.3 India Antivenom Sales Breakdown by Application
11.3.1 India Antivenom Sales Breakdown by Application (2016-2021)
11.3.2 India Antivenom Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Antivenom Business
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Business Overview
12.1.3 CSL Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Antivenom Products Offered
12.1.5 CSL Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Antivenom Products Offered
12.2.5 Merck Recent Development
12.3 BTG
12.3.1 BTG Corporation Information
12.3.2 BTG Business Overview
12.3.3 BTG Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.3.4 BTG Antivenom Products Offered
12.3.5 BTG Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Antivenom Products Offered
12.4.5 Pfizer Recent Development
12.5 Haffkine Bio-Pharmaceutical
12.5.1 Haffkine Bio-Pharmaceutical Corporation Information
12.5.2 Haffkine Bio-Pharmaceutical Business Overview
12.5.3 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Haffkine Bio-Pharmaceutical Antivenom Products Offered
12.5.5 Haffkine Bio-Pharmaceutical Recent Development
12.6 Rare Disease Therapeutics
12.6.1 Rare Disease Therapeutics Corporation Information
12.6.2 Rare Disease Therapeutics Business Overview
12.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Rare Disease Therapeutics Antivenom Products Offered
12.6.5 Rare Disease Therapeutics Recent Development
12.7 Flynn Pharma
12.7.1 Flynn Pharma Corporation Information
12.7.2 Flynn Pharma Business Overview
12.7.3 Flynn Pharma Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Flynn Pharma Antivenom Products Offered
12.7.5 Flynn Pharma Recent Development
12.8 Vins Bioproducts
12.8.1 Vins Bioproducts Corporation Information
12.8.2 Vins Bioproducts Business Overview
12.8.3 Vins Bioproducts Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Vins Bioproducts Antivenom Products Offered
12.8.5 Vins Bioproducts Recent Development
12.9 Bharat Serums and Vaccines
12.9.1 Bharat Serums and Vaccines Corporation Information
12.9.2 Bharat Serums and Vaccines Business Overview
12.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bharat Serums and Vaccines Antivenom Products Offered
12.9.5 Bharat Serums and Vaccines Recent Development
12.10 Serum Biotech
12.10.1 Serum Biotech Corporation Information
12.10.2 Serum Biotech Business Overview
12.10.3 Serum Biotech Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Serum Biotech Antivenom Products Offered
12.10.5 Serum Biotech Recent Development
12.11 MicroPharm
12.11.1 MicroPharm Corporation Information
12.11.2 MicroPharm Business Overview
12.11.3 MicroPharm Antivenom Sales, Revenue and Gross Margin (2016-2021)
12.11.4 MicroPharm Antivenom Products Offered
12.11.5 MicroPharm Recent Development
13 Antivenom Manufacturing Cost Analysis
13.1 Antivenom Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antivenom
13.4 Antivenom Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antivenom Distributors List
14.3 Antivenom Customers
15 Market Dynamics
15.1 Antivenom Market Trends
15.2 Antivenom Drivers
15.3 Antivenom Market Challenges
15.4 Antivenom Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antivenom Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Antivenom Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Antivenom Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Antivenom Sales (K Vials) by Region (2016-2021)
Table 5. Global Antivenom Sales Market Share by Region (2016-2021)
Table 6. Global Antivenom Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Antivenom Revenue Share by Region (2016-2021)
Table 8. Global Antivenom Sales (K Vials) Forecast by Region (2022-2027)
Table 9. Global Antivenom Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Antivenom Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Antivenom Revenue Share Forecast by Region (2022-2027)
Table 12. Global Antivenom Sales (K Vials) of Key Companies (2016-2021)
Table 13. Global Antivenom Sales Share by Company (2016-2021)
Table 14. Global Antivenom Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Antivenom Revenue Share by Company (2016-2021)
Table 16. Global Antivenom by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom as of 2020)
Table 17. Global Antivenom Average Price (USD/Vial) of Key Company (2016-2021)
Table 18. Manufacturers Antivenom Manufacturing Sites and Area Served
Table 19. Manufacturers Antivenom Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Antivenom Sales (K Vials) by Type (2016-2021)
Table 22. Global Antivenom Sales Share by Type (2016-2021)
Table 23. Global Antivenom Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Antivenom Price (USD/Vial) by Type (2016-2021)
Table 25. Global Antivenom Sales Share by Type (2022-2027)
Table 26. Global Antivenom Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Antivenom Revenue Share by Type (2022-2027)
Table 28. Global Antivenom Price (USD/Vial) by Type (2022-2027)
Table 29. Global Antivenom Sales (K Vials) by Application (2016-2021)
Table 30. Global Antivenom Sales Share by Application (2016-2021)
Table 31. Global Antivenom Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Antivenom Price (USD/Vial) by Application (2016-2021)
Table 33. Global Antivenom Sales (K Vials) by Application (2022-2027)
Table 34. Global Antivenom Sales Share by Application (2022-2027)
Table 35. Global Antivenom Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Antivenom Revenue Share by Application (2022-2027)
Table 37. Global Antivenom Price (USD/Vial) by Application (2022-2027)
Table 38. North America Antivenom Sales (K Vials) by Company (2016-2021)
Table 39. North America Antivenom Sales Market Share by Company (2016-2021)
Table 40. North America Antivenom Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Antivenom Revenue Market Share by Company (2016-2021)
Table 42. North America Antivenom Sales by Type (2016-2021) & (K Vials)
Table 43. North America Antivenom Sales Market Share by Type (2016-2021)
Table 44. North America Antivenom Sales by Type (2022-2027) & (K Vials)
Table 45. North America Antivenom Sales Market Share by Type (2022-2027)
Table 46. North America Antivenom Sales by Application (2016-2021) & (K Vials)
Table 47. North America Antivenom Sales Market Share by Application (2016-2021)
Table 48. North America Antivenom Sales by Application (2022-2027) & (K Vials)
Table 49. North America Antivenom Sales Market Share by Application (2022-2027)
Table 50. Europe Antivenom Sales (K Vials) by Company (2016-2021)
Table 51. Europe Antivenom Sales Market Share by Company (2016-2021)
Table 52. Europe Antivenom Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Antivenom Revenue Market Share by Company (2016-2021)
Table 54. Europe Antivenom Sales by Type (2016-2021) & (K Vials)
Table 55. Europe Antivenom Sales Market Share by Type (2016-2021)
Table 56. Europe Antivenom Sales by Type (2022-2027) & (K Vials)
Table 57. Europe Antivenom Sales Market Share by Type (2022-2027)
Table 58. Europe Antivenom Sales by Application (2016-2021) & (K Vials)
Table 59. Europe Antivenom Sales Market Share by Application (2016-2021)
Table 60. Europe Antivenom Sales by Application (2022-2027) & (K Vials)
Table 61. Europe Antivenom Sales Market Share by Application (2022-2027)
Table 62. China Antivenom Sales (K Vials) by Company (2016-2021)
Table 63. China Antivenom Sales Market Share by Company (2016-2021)
Table 64. China Antivenom Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Antivenom Revenue Market Share by Company (2016-2021)
Table 66. China Antivenom Sales by Type (2016-2021) & (K Vials)
Table 67. China Antivenom Sales Market Share by Type (2016-2021)
Table 68. China Antivenom Sales by Type (2022-2027) & (K Vials)
Table 69. China Antivenom Sales Market Share by Type (2022-2027)
Table 70. China Antivenom Sales by Application (2016-2021) & (K Vials)
Table 71. China Antivenom Sales Market Share by Application (2016-2021)
Table 72. China Antivenom Sales by Application (2022-2027) & (K Vials)
Table 73. China Antivenom Sales Market Share by Application (2022-2027)
Table 74. Japan Antivenom Sales (K Vials) by Company (2016-2021)
Table 75. Japan Antivenom Sales Market Share by Company (2016-2021)
Table 76. Japan Antivenom Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Antivenom Revenue Market Share by Company (2016-2021)
Table 78. Japan Antivenom Sales by Type (2016-2021) & (K Vials)
Table 79. Japan Antivenom Sales Market Share by Type (2016-2021)
Table 80. Japan Antivenom Sales by Type (2022-2027) & (K Vials)
Table 81. Japan Antivenom Sales Market Share by Type (2022-2027)
Table 82. Japan Antivenom Sales by Application (2016-2021) & (K Vials)
Table 83. Japan Antivenom Sales Market Share by Application (2016-2021)
Table 84. Japan Antivenom Sales by Application (2022-2027) & (K Vials)
Table 85. Japan Antivenom Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Antivenom Sales (K Vials) by Company (2016-2021)
Table 87. Southeast Asia Antivenom Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Antivenom Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Antivenom Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Antivenom Sales by Type (2016-2021) & (K Vials)
Table 91. Southeast Asia Antivenom Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Antivenom Sales by Type (2022-2027) & (K Vials)
Table 93. Southeast Asia Antivenom Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Antivenom Sales by Application (2016-2021) & (K Vials)
Table 95. Southeast Asia Antivenom Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Antivenom Sales by Application (2022-2027) & (K Vials)
Table 97. Southeast Asia Antivenom Sales Market Share by Application (2022-2027)
Table 98. India Antivenom Sales (K Vials) by Company (2016-2021)
Table 99. India Antivenom Sales Market Share by Company (2016-2021)
Table 100. India Antivenom Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Antivenom Revenue Market Share by Company (2016-2021)
Table 102. India Antivenom Sales by Type (2016-2021) & (K Vials)
Table 103. India Antivenom Sales Market Share by Type (2016-2021)
Table 104. India Antivenom Sales by Type (2022-2027) & (K Vials)
Table 105. India Antivenom Sales Market Share by Type (2022-2027)
Table 106. India Antivenom Sales by Application (2016-2021) & (K Vials)
Table 107. India Antivenom Sales Market Share by Application (2016-2021)
Table 108. India Antivenom Sales by Application (2022-2027) & (K Vials)
Table 109. India Antivenom Sales Market Share by Application (2022-2027)
Table 110. CSL Corporation Information
Table 111. CSL Description and Business Overview
Table 112. CSL Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 113. CSL Antivenom Product
Table 114. CSL Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 118. Merck Antivenom Product
Table 119. Merck Recent Development
Table 120. BTG Corporation Information
Table 121. BTG Description and Business Overview
Table 122. BTG Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 123. BTG Antivenom Product
Table 124. BTG Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 128. Pfizer Antivenom Product
Table 129. Pfizer Recent Development
Table 130. Haffkine Bio-Pharmaceutical Corporation Information
Table 131. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 132. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 133. Haffkine Bio-Pharmaceutical Antivenom Product
Table 134. Haffkine Bio-Pharmaceutical Recent Development
Table 135. Rare Disease Therapeutics Corporation Information
Table 136. Rare Disease Therapeutics Description and Business Overview
Table 137. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 138. Rare Disease Therapeutics Antivenom Product
Table 139. Rare Disease Therapeutics Recent Development
Table 140. Flynn Pharma Corporation Information
Table 141. Flynn Pharma Description and Business Overview
Table 142. Flynn Pharma Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 143. Flynn Pharma Antivenom Product
Table 144. Flynn Pharma Recent Development
Table 145. Vins Bioproducts Corporation Information
Table 146. Vins Bioproducts Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 147. Vins Bioproducts Description and Business Overview
Table 148. Vins Bioproducts Antivenom Product
Table 149. Vins Bioproducts Recent Development
Table 150. Bharat Serums and Vaccines Corporation Information
Table 151. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 152. Bharat Serums and Vaccines Description and Business Overview
Table 153. Bharat Serums and Vaccines Antivenom Product
Table 154. Bharat Serums and Vaccines Recent Development
Table 155. Serum Biotech Corporation Information
Table 156. Serum Biotech Description and Business Overview
Table 157. Serum Biotech Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 158. Serum Biotech Antivenom Product
Table 159. Serum Biotech Recent Development
Table 160. MicroPharm Corporation Information
Table 161. MicroPharm Description and Business Overview
Table 162. MicroPharm Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 163. MicroPharm Antivenom Product
Table 164. MicroPharm Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Antivenom Distributors List
Table 168. Antivenom Customers List
Table 169. Antivenom Market Trends
Table 170. Antivenom Market Drivers
Table 171. Antivenom Market Challenges
Table 172. Antivenom Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenom Product Picture
Figure 2. Global Antivenom Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antivenom Sales Market Share by Application in 2021 & 2027
Figure 6. Non-profit Institutions Examples
Figure 7. Hospitals and Clinic Examples
Figure 8. Global Antivenom Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Antivenom Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Antivenom Sales (K Vials) Growth Rate (2016-2027)
Figure 11. Global Antivenom Price Trends Growth Rate (2016-2027) (USD/Vial)
Figure 12. Global Antivenom Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Antivenom Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Antivenom Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Antivenom Sales (K Vials) Growth Rate (2016-2027)
Figure 16. Europe Antivenom Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Antivenom Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Antivenom Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Antivenom Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Antivenom Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Antivenom Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Antivenom Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Antivenom Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Antivenom Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Antivenom Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Antivenom Players Market Share by Revenue in Antivenom: 2016 & 2020
Figure 27. Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Antivenom Revenue Share by Type (2016-2021)
Figure 29. Global Antivenom Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Antivenom Revenue Share by Application (2016-2021)
Figure 31. Global Antivenom Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Antivenom Sales Market Share by Type in 2020
Figure 33. North America Antivenom Sales Market Share by Application in 2020
Figure 34. Europe Antivenom Sales Market Share by Type in 2020
Figure 35. Europe Antivenom Sales Market Share by Application in 2020
Figure 36. China Antivenom Sales Market Share by Type in 2020
Figure 37. China Antivenom Sales Market Share by Application in 2020
Figure 38. Japan Antivenom Sales Market Share by Type in 2020
Figure 39. Japan Antivenom Sales Market Share by Application in 2020
Figure 40. Southeast Asia Antivenom Sales Market Share by Type in 2020
Figure 41. Southeast Asia Antivenom Sales Market Share by Application in 2020
Figure 42. India Antivenom Sales Market Share by Type in 2020
Figure 43. India Antivenom Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Antivenom
Figure 46. Manufacturing Process Analysis of Antivenom
Figure 47. Antivenom Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
セボフルランのグローバル市場2021 Market Analysis and Insights: Global Sevoflurane Market The global Sevoflurane market was valued at US$ 1322.6 in 2020 and will reach US$ 1283.5 million by the end of 2027, growing at a CAGR of -0.5% during 2022-2027. Global Sevoflurane Scope and Market Size The global Sevoflurane market is segmente…- アリシンのグローバル市場2021 Allicin (CAS 539-86-6) is the major biologically active component of garlic. First reported by Cavallito and Bailey in 1944, Allicin (CAS 539-86-6) is the key ingredient responsible for the broad-spectrum of anti-bacterial activity in garlic. They are usually used for dietary supplement. Allicin (CA…
- リダプトのグローバル市場2021 Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% In 2018. Following Nor…
- ペグアスパラガーゼのグローバル市場2021 Oncaspar is a cancer medicine used in adults and children to treat acute lymphoblastic leukaemia (ALL), a cancer of white blood cells called lymphoblasts. Oncaspar is used in combination with other cancer medicines. Servier was the global greatest and the only one company in Oncaspar industry. Marke…
- プロチオコナゾールのグローバル市場2021 Prothioconazole is one of two triazole fungicides (the other being epoxiconazole) reported to still provide a high level of eradicative and protective control of Septoria tritici. Geographically, the global Prothioconazole market has been segmented into EMEA, Latin America, North America and Asia Pa…